Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition
mBio · 2026
DOI: 10.1128/mbio.02432-25 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift mBio, 2026. Verfasst von Erin Yuan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Harvard University, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harvard Global Health Institute, Danish National Research Foundation, JPB Foundation.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines reduced severe coronavirus disease 2019, but variants like Delta and Omicron caused widespread breakthrough infections (BIs). Mexico, offering diverse vaccines, and its Yucatán region, a major travel hub, provide a unique setting to study BIs. We characterized SARS-CoV-2 BIs in Yucatán during the Delta-to-Omicron transition (September 2021–January 2022), assessing disease severity, symptoms, and viral transmission dynamics using epidemiological and genomic data. A case-control study using health system data ( n = 13,325) compared outcomes in BIs ( n = 5,183) versus unvaccinated infections (UIs; n = 8,142) via logistic regression, also comparing Delta versus Omicron waves. Phylodynamic modeling of 205 BI sequences, contextualized globally ( n = 1,152 total), reconstructed the evolutionary history and transmission routes. Vaccination significantly reduced hospitalization (odds ratio [OR] = 0.38) and death (OR = 0.45) in BIs compared to UIs. Omicron infections were less severe than Delta (hospitalization OR = 0.60; death OR = 0.33) and presented with less loss of smell/taste but more upper respiratory symptoms. Phylodynamics revealed numerous introductions (17 Delta, 36 Omicron). Delta BIs in Yucatán originated mainly from within Mexico, Guatemala, Europe, and the United States. Omicron BIs in Yucatán had more diverse origins including from North and South America and Africa, coinciding with eased travel restrictions. Vaccines maintained protection against severe outcomes during the Delta and Omicron waves in Yucatán. Omicron, though less severe, showed enhanced transmissibility with increased introductions linked to relaxed public health measures. Findings highlight the critical role of continued vaccination, genomic surveillance, adaptive policies, and cross-border collaboration for pandemic preparedness and health security. IMPORTANCE Our understanding of severe acute respiratory syndrome coronavirus 2 breakthrough infections in Latin America is limited, specifically in regions with unique epidemiological dynamics. In this study, we fill a knowledge gap by characterizing these infections in Yucatán, Mexico, a major international travel hub with one of the world's most diverse vaccine rollouts, during the critical transition from the Delta variant to the Omicron variant. The translational importance of our investigation is twofold. First, through case-control data analysis, we provide robust, real-world evidence that vaccination significantly reduced the risk of hospitalization and death, offering crucial data to support ongoing vaccination campaigns against emerging variants. Second, by combining epidemiological data with phylodynamic analysis, we demonstrate a direct link between the easing of public health restrictions and the increased number and diversity of viral introductions that sparked the Omicron wave. This highlights the critical importance of coordinating genomic tracking with public health policy to mitigate the spread of future pandemic threats and strengthen global health security.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard University, Cambridge, Massachusetts, USA.
- Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
- PandemiX Center of Excellence, Roskilde University, Roskilde, Denmark.
- National Institute of Health, Islamabad, Pakistan.
- Department of Paediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
- Laboratorio de Virología, CIR-Biomédicas, Universidad Autónoma Yucatán, Mérida, México.
ORCID-Profile: Guadalupe Ayora-Talavera, Nidia S Trovao
Förderung
- Harvard Global Health Institute
- Danish National Research Foundation
- JPB Foundation
- Conacyt
Zitieren
APA
Yuan, E., Hansen, C. L., Tamim, S., Kanwar, S., Spiro, D. J., Gonzalez-Losa, R., Conde-Ferraez, L., Granja-Pérez, P., Villanueva-Jorge, S., López-Martínez, I., Barrea-Badillo, G., Corvelo, A., Fennessey, S., Zody, M. C., Ayora-Talavera, G., & Trovao, N. S. (2026). Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition. mBio. https://doi.org/10.1128/mbio.02432-25
Vancouver
Yuan E, Hansen CL, Tamim S, Kanwar S, Spiro DJ, Gonzalez-Losa R, et al. Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition. mBio. 2026. doi:10.1128/mbio.02432-25
BibTeX
@article{Yuan2026,
author = {Yuan, Erin and Hansen, Chelsea L and Tamim, Sana and Kanwar, Samia and Spiro, David J and Gonzalez-Losa, Refugio and Conde-Ferraez, Laura and Granja-Pérez, Pilar and Villanueva-Jorge, Salha and López-Martínez, Irma and Barrea-Badillo, Gisela and Corvelo, André and Fennessey, Samantha and Zody, Michael C and Ayora-Talavera, Guadalupe and Trovao, Nidia S},
title = {Case-control and genomic epidemiology characterization of SARS-CoV-2 breakthrough infections during the Delta-to-Omicron transition},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.02432-25}
}
EUVIMED